Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Drug Therapy × Sarcoma × Clear all

Status

Completed 11 Recruiting 8 Unknown 7 Terminated 4 Withdrawn 3 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 38 Thoracic 31 Breast 8 Head & Neck 6 Gynecologic 6 Genitourinary 6 Plasma cell 2 Other solid neoplasm 2 Other hematologic neoplasm 2 Lymphoid 2 Sarcoma 1 CNS 1

Conditions

Interventions

Doxorubicin 6 Cyclophosphamide 6 X-Rays 3 Vincristine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 polatuzumab vedotin 2 pemigatinib 2 liposomal doxorubicin 2 fludarabine 2 envafolimab 2 anlotinib 2 Radiotherapy 2 Prednisone 2 Injections 2 Imatinib Mesylate 2 Ifosfamide 2 Etoposide 2 Biopsy 2 AZD 6244 2 toripalimab 1 surufatinib 1 regorafenib 1 perflutren 1 pazopanib 1 montelukast 1 lenvatinib 1 glofitamab 1 eribulin 1 elacestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06776198 2025-01-24

PTMTO

Peking University People's Hospital

Not yet recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡